PHARMACOLOGICAL NAD+ BOOSTING EXHIBITS THERAPEUTIC POTENTIAL BY PRESERVING MITOCHONDRIAL INTEGRITY FROM PARKINSON’S- AND ALZHEIMER’S-RELATED NEURODEGENERATION

• Noel Calingasan,
• Jayandra Chiluwal,
• Anatoly Starkov,
• Gary Gibson,
• Carlos Villalobos,
• Lucia Núñez,
• Victor Tapias

Affiliations

Noel Calingasan

Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America

Jayandra Chiluwal

Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America

Anatoly Starkov

Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America; Robert Wood Johnson Medical School. Rutgers University, Pediatrics, New Jersey, United States of America

Gary Gibson

Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America; Weill Cornell Medicine, Burke Neurological Institute, White Plains, United States of America

Carlos Villalobos

CSIC - University of Valladolid, Institute Of Genetics And Molecular Biology, Valladolid, Spain

Lucia Núñez

CSIC - University of Valladolid, Institute Of Genetics And Molecular Biology, Valladolid, Spain; University of Valladolid Medical School, Dept. Biochemistry And Molecular Biology And Physiology, Valladolid, Spain

Victor Tapias

Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America; CSIC - University of Valladolid, Institute Of Genetics And Molecular Biology, Valladolid, Spain; University of Valladolid Medical School, Dept. Biochemistry And Molecular Biology And Physiology, Valladolid, Spain